BACTech and SteinCares have signed a protocol granting Stein exclusive commercialization rights for BAT2406 injection in the Brazilian and Latin American markets, with a total amount of up to 10 million USD. After the protocol takes effect, BACTech will receive revenue sharing based on sales, which is expected to have a positive impact on the company's future performance.

On December 16th, Jin10 Data reported that the company signed an authorization license, production, supply, and commercialization protocol with SteinCares, granting Stein the exclusive product commercialization rights of the company's BAT2306 (Saccuhippus monoclonal antibody) injection in the Brazilian and other Latin American markets. The transaction amount is up to a total of 8 million US dollars, including a down payment of 1.2 million US dollars, cumulative milestone payments not exceeding 6.8 million US dollars, and a two-digit percentage of net sales as revenue sharing.

ChainCatcher message, according to Arkham data, Grayscale Basic Attention Token Trust increased its holdings by 2.191 million BAT today, worth approximately 49.158

Golden Finance reported that according to Arkham monitoring data, about three hours ago, Grayscale through its subsidiary Grayscale Basic Attention Token

Odaily Planet Daily News According to Arkham monitoring, approximately 10 minutes ago, 5910 LINK flowed into the Grayscale Chainlink Trust of Chainlink; and approximately 9 minutes ago, 41822 BAT flowed into the Grayscale Basic Attention Token Trust of BAT.

Gold 10 Data October 3rd News, local time October 3rd, early morning, the Israeli Defense Forces issued a statement, saying that earlier in the day, Bat Yam, south of Tel Aviv,

PANews 17th December news, according to Grayscale official announcement, its Cryptocurrency product portfolio now covers 30 digital assets, including $AAVE, $AVAX, $BAT, $BCH, $FIL, $GRT, $LDO, $LINK, $LPT, $LTC, $MANA, $MKR, $NEAR, $OP, $RENDER, $SOL, $STX, $SUI, $TAO, $XLM, $XRP, and $ZEC.